Becker's Hospital Review

The value of early intervention with Collagenase SANTYL Ointment

A large-scale, real-world analysis of 15,639 patients treated with Collagenase SANTYL Ointment underscores the clinical and economic benefits of early enzymatic debridement in wound management. Using ...
Seeking Alpha

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

YAVNE, Israel, Feb. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the results of head-to-head ...
Medindia

Healthpoint Launches Collagenase SANTYL(R) Ointment in Canada

FORT WORTH, Texas and PETERBOROUGH, Ontario, Jan. 26 Healthpoint today announced that it will begin marketing Collagenase SANTYL® Ointment to healthcare professionals in Canada. SANTYL® Ointment is a ...
Yahoo Finance

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Mena FN

Mediwound Announces Positive Results In Head-To-Head Comparison Of Escharex® Vs. SANTYL® Within The Chronex Phase II Randomized Controlled Study

(MENAFN- GlobeNewsWire - Nasdaq) Results demonstrate superiority of EscharEx®, a bromelain-based gel vs. SANTYL®, a collagenase ointment, in wound debridement, promotion of granulation tissue, and ...